Tuesday, February 26, 2008 4:54:53 PM
Tuesday February 26, 2:08 pm ET
Emeryville's Onyx Pharmaceuticals Inc. has tapped Dr. Anthony Coles as its new president and chief executive officer and a member of the board of directors, the company said Tuesday.
He will succeed Hollings Renton at Onyx (NASDAQ: ONXX - News). Renton announced his retirement plans last October. Renton had said he would remain as chairman, but the company said Tuesday he would retire on the same date.
Coles is the former chief executive and member of the board of directors of NPS Pharmaceuticals Inc., a biotechnology company in Bedminster, N.J.
Before that, he held management roles at several other East Coast pharmaceutical companies including Vertex Pharmaceuticals Inc., Bristol-Myers Squibb Co. and Merck & Co. Inc.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM